$KITL
Kisses From Italy Inc. Stock $kitl

$kitl Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003197 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$61.38K	$115.5K	$97.83K
YoY Change	-45.26%	18.02%	-14.69%
Cost Of Revenue	$29.12K	$58.87K	$45.18K
YoY Change	-52.08%	30.3%	-14.22%
Gross Profit	$32.26K	$56.59K	$52.65K
YoY Change	-37.2%	7.48%	-15.09%
Gross Profit Margin	52.56%	49.01%	53.82%
Selling, General & Admin	$1.227M	$530.8K	$202.9K
YoY Change	789.77%	161.55%	-57.51%
% of Gross Profit	3802.19%	937.92%	385.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$526.00	$527.00	$530.00
YoY Change	0.0%	-0.57%	-82.45%
% of Gross Profit	1.63%	0.93%	1.01%
Operating Expenses	$1.227M	$531.3K	$203.5K
YoY Change	786.76%	161.14%	-57.67%
Operating Profit	-$1.195M	-$474.7K	-$150.8K
YoY Change	1273.19%	214.78%	-63.97%
Interest Expense	-$164.9K	-$309.6K	-$2.290K
YoY Change	-45.07%	13420.96%	9.05%
% of Operating Profit
Other Income/Expense, Net	-$164.9K	-$477.7K	-$2.293K
YoY Change	-45.07%	20732.4%
Pretax Income	-$1.360M	-$952.4K	-$153.1K
YoY Change	251.15%	522.11%	-63.61%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.359M	-$950.5K	-$150.2K
YoY Change	234.12%	532.8%	-64.39%
Net Earnings / Revenue	-2213.54%	-823.23%	-153.54%
Basic Earnings Per Share	-$0.01	$0.00	$0.00
Diluted Earnings Per Share	-$0.01	$0.00	-$818.40
COMMON SHARES
Basic Shares Outstanding	225.2M shares	210.2M shares	183.5M shares
Diluted Shares Outstanding	222.8M shares	194.6M shares	183.5M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$55.04K	$34.26K	$25.10K
YoY Change	-80.15%	36.49%	-53.9%
Cash & Equivalents	$55.04K	$34.26K	$25.10K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$12.32K	$15.50K	$10.85K
Prepaid Expenses
Receivables	$14.76K	$13.67K	$14.69K
Other Receivables	$49.19K	$49.19K	$32.03K
Total Short-Term Assets	$131.3K	$112.6K	$82.66K
YoY Change	-65.71%	36.24%	12.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.633K	$3.160K	$546.1K
YoY Change	-44.45%	-99.42%	7309.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.745K	$2.745K	$2.750K
YoY Change	0.0%	-0.18%	152.29%
Total Long-Term Assets	$472.3K	$496.6K	$548.9K
YoY Change	-10.29%	-9.52%	6380.05%
TOTAL ASSETS
Total Short-Term Assets	$131.3K	$112.6K	$82.66K
Total Long-Term Assets	$472.3K	$496.6K	$548.9K
Total Assets	$603.6K	$609.2K	$631.5K
YoY Change	-33.62%	-3.53%	668.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$97.51K	$72.34K	$77.96K
YoY Change	15.59%	-7.21%	33.26%
Accrued Expenses	$108.1K	$132.5K	$186.5K
YoY Change	-30.54%	-28.99%	24.78%
Deferred Revenue
YoY Change
Short-Term Debt	$230.0K	$326.6K	$0.00
YoY Change	-54.2%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$479.3K	$715.7K	$273.4K
YoY Change	-39.15%	161.77%	31.46%
LONG-TERM LIABILITIES
Long-Term Debt	$308.5K	$250.0K	$22.17K
YoY Change		1027.65%	0.0%
Other Long-Term Liabilities	$382.4K	$405.2K	$473.6K
YoY Change	-19.24%	-14.43%
Total Long-Term Liabilities	$691.0K	$655.2K	$495.7K
YoY Change	45.91%	32.17%	2136.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$479.3K	$715.7K	$273.4K
Total Long-Term Liabilities	$691.0K	$655.2K	$495.7K
Total Liabilities	$1.170M	$1.371M	$746.6K
YoY Change	-7.21%	83.63%	258.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.02M	-$15.66M
YoY Change	18.03%
Common Stock	$250.0K	$210.2K
YoY Change	34.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$530.7K	-$726.9K	-$115.1K
YoY Change
Total Liabilities & Shareholders Equity	$603.6K	$609.2K	$631.5K
YoY Change	-33.62%	-3.53%	668.93%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.359M	-$950.5K	-$150.2K
YoY Change	234.12%	532.8%	-64.39%
Depreciation, Depletion And Amortization	$526.00	$527.00	$530.00
YoY Change	0.0%	-0.57%	-82.45%
Cash From Operating Activities	-$225.5K	-$290.2K	-$119.4K
YoY Change	-1.03%	143.1%	-5.23%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	246.3K	$0.00	5.000K
YoY Change	-48.68%	-100.0%	-96.55%
NET CHANGE
Cash From Operating Activities	-225.5K	-$290.2K	-119.4K
Cash From Investing Activities	0.000	$0.00	0.000
Cash From Financing Activities	246.3K	$0.00	5.000K
Net Change In Cash	20.79K	-$290.2K	-114.4K
YoY Change	-91.75%	153.73%	-768.56%
FREE CASH FLOW
Cash From Operating Activities	-$225.5K	-$290.2K	-$119.4K
Capital Expenditures	$0.00		$0.00
Free Cash Flow	-$225.5K		-$119.4K
YoY Change	-1.03%		-3.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001608092
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-52898
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Kisses From Italy Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2388377
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 SW
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	8th Street
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 2000
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33130
CY2023Q1	dei	City Area Code CityAreaCode	(305)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	423-7129
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	225225926	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34255	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324493	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13672	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13470	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	49190	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	49190	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	15500	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14359	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	112617	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	401511	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3160	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3687	usd
CY2023Q1	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2022Q4	kitl	Equipment Not In Service EquipmentNotInService	40852	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	449832	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	473561	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2745	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2745	usd
CY2023Q1	us-gaap	Assets Assets	609206	usd
CY2022Q4	us-gaap	Assets Assets	922355	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	72336	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	86393	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132458	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	149393	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	44619	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	45577	usd
CY2023Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	12171	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	12171	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	314400	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	488400	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	139740	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	73398	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	715723	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	855333	usd
CY2023Q1	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	250000	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	250000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405213	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	427984	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1370937	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1533317	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	210220534	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	210220534	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189216582	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189216582	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	210220	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	189216	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14719659	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13939053	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15656889	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14706391	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-726864	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-577977	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-34868	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-32985	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-761732	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-610962	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	609206	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	922355	usd
CY2023Q1	us-gaap	Revenues Revenues	115460	usd
CY2022Q1	us-gaap	Revenues Revenues	97827	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	58871	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	45176	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	56589	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	52651	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	0	usd
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	5170	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	206700	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	53440	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	45833	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32357	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32888	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	150757	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	61103	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87501	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57931	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	531283	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	203452	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-474694	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-150801	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-243285	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2293	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-168060	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	66342	usd
CY2022Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-477687	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2293	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-952381	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-153094	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-153094	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1883	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2889	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-150205	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	194550922	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	183546915	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	194550922	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	183546915	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5295	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5170	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-2889	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-150205	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-137629	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-610962	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-950498	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-1883	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable CommonStockIssuedForAccountsPayable	15050	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Shares Value IssuanceOfCommonStockAsFinancingCommitmentSharesValue	198000	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock Value ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStockValue	381860	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-761732	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-952381	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-153094	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	527	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	168060	usd
CY2022Q1	us-gaap	Extinguishment Of Debt Gain Loss Income Tax ExtinguishmentOfDebtGainLossIncomeTax	0	usd
CY2023Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	206700	usd
CY2022Q1	kitl	Stockbased Compensation For Services StockbasedCompensationForServices	5170	usd
CY2023Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	66342	usd
CY2022Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	0	usd
CY2023Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	198000	usd
CY2022Q1	kitl	Issuance Of Financing Commitment Shares IssuanceOfFinancingCommitmentShares	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1791	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-0	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-16414	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1141	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5579	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1007	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	25290	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24865	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6327	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-290238	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-119390	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-290238	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-114390	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	324493	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	139485	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34255	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25095	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	381860	usd
CY2022Q1	kitl	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	0	usd
CY2023Q1	kitl	Reduction Of Accounts Payable With Common Stock ReductionOfAccountsPayableWithCommonStock	15050	usd
CY2022Q1	kitl	Reduction Of Accounts Payable With Common Stock ReductionOfAccountsPayableWithCommonStock	0	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zDtpCxFuXwgl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_z4hqxB1Nrpwa">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, valuation of financial instruments, income taxes, and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13672	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13470	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	kitl	Employee Retention Credit EmployeeRetentionCredit	27190	usd
CY2022Q4	kitl	Employee Retention Credit EmployeeRetentionCredit	27190	usd
CY2023Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	0	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	0	usd
CY2023Q1	kitl	Franchisee Receivable FranchiseeReceivable	22000	usd
CY2022Q4	kitl	Franchisee Receivable FranchiseeReceivable	22000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	73398	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable CommonStockIssuedForAccountsPayable	15050	usd
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Shares IssuanceOfCommonStockAsFinancingCommitmentShareShares	1607000	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34255	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	324493	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	139740	usd
CY2023Q1	kitl	Right Of Use Operating Assets RightOfUseOperatingAssets	562000	usd
CY2023Q1	kitl	Right Of Use Operating Lease Liabilities RightOfUseOperatingLeaseLiabilities	562000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	15500	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	14359	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	6000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	206700	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Shares IssuanceOfCommonStockAsFinancingCommitmentShareShares	6000000	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34255	usd
CY2023Q1	kitl	Working Capital WorkingCapital	603107	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15656889	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3160	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3687	usd
CY2023Q1	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	198000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	8552000	shares
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	381860	usd
CY2023Q1	kitl	Common Stock Issued For Accounts Payable Shares CommonStockIssuedForAccountsPayableShares	451952	shares
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	7829	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3957	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	28177	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	50330	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	96452	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	95106	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	132458	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	149393	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	49455	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	46997	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	262171	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	262171	usd
CY2023Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.08	pure
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	314400	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	488400	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	139740	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	73398	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.12	pure
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.025
CY2022	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	100167	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	139740	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	210220534	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	210220534	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	189216582	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	189216582	shares
CY2022	kitl	Issuance Of Common Stock As Financing Commitment Share Value IssuanceOfCommonStockAsFinancingCommitmentShareValue	97453	usd
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3696000	shares
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	58027	usd
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
CY2021	kitl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod	0	shares
CY2021	kitl	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2021	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2021	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0
CY2022	kitl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod	5018000	shares
CY2022	kitl	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	0.10055
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2022	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5018000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10055
CY2023Q1	kitl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod	0	shares
CY2023Q1	kitl	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2023Q1	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2023Q1	kitl	Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5018000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10055
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16000000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	562030	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	88469	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	473561	usd
CY2023Q1	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	32357	usd
CY2022Q1	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	32888	usd

Files In Submission

Name	View Source	Status
0001683168-23-003197-index-headers.html	Edgar Link	pending
0001683168-23-003197-index.html	Edgar Link	pending
0001683168-23-003197.txt	Edgar Link	pending
0001683168-23-003197-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kisses_ex3101.htm	Edgar Link	pending
kisses_ex3102.htm	Edgar Link	pending
kisses_ex3201.htm	Edgar Link	pending
kisses_ex3202.htm	Edgar Link	pending
kisses_i10q-033123.htm	Edgar Link	pending
kitl-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kitl-20230331_cal.xml	Edgar Link	unprocessable
kisses_i10q-033123_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kitl-20230331_def.xml	Edgar Link	unprocessable
kitl-20230331_lab.xml	Edgar Link	unprocessable
kitl-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KITL
Kisses From Italy Inc. Stock $kitl

2023 Q2 Form 10-Q Financial Statement

#000168316823003197 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITL Kisses From Italy Inc. Stock $kitl

2023 Q2 Form 10-Q Financial Statement

#000168316823003197 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KITL
Kisses From Italy Inc. Stock $kitl